SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 367 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,818 | +5.8% | 15 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,718 | -16.9% | 15 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $2,067 | +6.3% | 15 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $1,944 | +17.2% | 15 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $1,658 | +47.5% | 15 | 0.0% | 0.00% | – |
| Q2 2022 | $1,124 | -4.1% | 15 | 0.0% | 0.00% | – |
| Q1 2022 | $1,172 | -13.2% | 15 | 0.0% | 0.00% | – |
| Q4 2021 | $1,351 | -18.9% | 15 | -16.7% | 0.00% | -100.0% |
| Q3 2021 | $1,665 | +33.8% | 18 | +12.5% | 0.00% | – |
| Q2 2021 | $1,244 | +864.3% | 16 | +1500.0% | 0.00% | – |
| Q4 2019 | $129 | -95.2% | 1 | -97.2% | 0.00% | -100.0% |
| Q3 2019 | $2,712 | -50.4% | 36 | 0.0% | 0.00% | -33.3% |
| Q2 2019 | $5,470 | +27.5% | 36 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $4,291 | -70.0% | 36 | -72.5% | 0.00% | -66.7% |
| Q4 2018 | $14,296 | -32.4% | 131 | 0.0% | 0.01% | -35.7% |
| Q3 2018 | $21,158 | +22.2% | 131 | 0.0% | 0.01% | +16.7% |
| Q2 2018 | $17,316 | – | 131 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |